Skip to main content
Figure 1 | BMC Medicine

Figure 1

From: Targeting insulin resistance in type 2 diabetes via immune modulation of cord blood-derived multipotent stem cells (CB-SCs) in stem cell educator therapy: phase I/II clinical trial

Figure 1

Improvement of metabolic control by stem cell educator therapy. (A) Twelve-week follow-up of HbA1C levels in T2D subjects. (B) Analysis of insulin sensitivity by HOMA-IR C-peptide at four weeks post-treatment with Stem Cell Educator therapy. (C) 56-week follow-up C-peptide levels in Group C T2D subjects with impaired islet β cell function. (D) Analysis of islet β cell function by HOMA-B C-peptide at 12-week follow-up post-treatment with Stem Cell Educator therapy in Group C T2D subjects.

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us